Merck's Q3 2025 results saw huge growth in Winrevair and Capvaxive sales. Check out why I maintain my Strong Buy rating on ...

We recently published 10 Trending Stocks This Week. Merck & Co., Inc. (NYSE:MRK) is one of the trending stocks this week.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...

MRK faces pressure from weak vaccine sales and rising competition, but strong oncology growth and new launches could support a rebound.

Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.

Johnson & Johnson JNJ and MerckMRK are leading U.S. healthcare giants, making them natural peers for a head-to-head ...

Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.7% year on year to $17.28 billion. The company expects the full year’s revenue to ...

Meta stock plunged more than 9% after the Facebook parent company reported third-quarter results. A strong performance from ...

Dow Jones stock Merck topped third-quarter forecasts on Thursday, but shares skidded as its challenges with vaccine Gardasil continued.

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access . * Reflecting concerns, ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...